Chidamide combined with azacitidine as a novel double epigenetic preemptive treatment for a myelodysplastic syndrome patient showing molecular relapse after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Annals of Hematology, 2024, v. 103, n. 12, p. 6003, doi. 10.1007/s00277-024-06137-5
- By:
- Publication type:
- Article